Dr. Jeffrey R. Jay, M.D. »

Avalo Therapeutics Ord shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 125k 18.16

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Zura Bio Class A Ord Shs (ZURA)
Disc Medicine (IRON)
Rapt Therapeutics Com New (RAPT)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Vor Biopharma Com New (VOR)
Dianthus Therapeutics (DNTH)
Jade Biosciences Com New (JBIO)
Kalvista Pharmaceuticals (KALV)
Contineum Therapeutics Cl A (CTNM)
Eupraxia Pharmaceuticals (EPRX)
Fulcrum Therapeutics (FULC)
Nektar Therapeutics Com New (NKTR)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Avalo Therapeutics Ord

BVF
Nantahala Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
RA Capital Management
Point72 Asset Management
Silverarc Capital Management
Marshall Wace
Citadel Advisors
Commodore Capital
TCG Crossover Management
UBS Group

View all funds holding Avalo Therapeutics Ord